Business Context and Reporting Period
This Form 8-K Current Report, dated May 14, 2025, pertains to Intuitive Surgical, Inc. (ISRG). The filing announces significant executive leadership changes effective July 1, 2025, including the appointment of a new Chief Executive Officer and the transition of the current CEO to Executive Chair.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on corporate governance and executive compensation adjustments.
Material Changes
- Executive Leadership Transition: David J. Rosa, currently President, is appointed CEO effective July 1, 2025. Gary S. Guthart, Ph.D., steps down as CEO to become Executive Chair of the Board.
- Board Composition: Craig H. Barratt, Ph.D., transitions from Chair to Lead Independent Director effective July 1, 2025.
- Compensation Adjustments:
- Dr. Guthart: Base salary reduced from $1,050,000 to $700,000. He is ineligible for future bonuses under the Corporate Incentive Program but eligible for a pro-rated 2025 bonus.
- Mr. Rosa: Base salary increased from $825,000 to $925,000. Targeted bonus opportunity increased from 125% to 150% of base salary.
- Equity Grants for Mr. Rosa:
- Restricted Stock Units (RSUs) with a target value of $4,000,000, vesting 25% annually over four years.
- Performance Stock Units (PSUs) with a target value of $4,000,000, vesting based on performance objectives by February 26, 2028.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of operational risks. It notes that the press release regarding these changes (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Investor Verification Checklist
- Confirm the exact vesting schedule and performance metrics for Mr. Rosa's $8,000,000 total equity grant.
- Verify the specific date of the press release (Exhibit 99.1) for additional context on the leadership transition.
- Monitor future filings for the impact of the leadership change on strategic direction and operational execution.
- Review the Company's 10-K or 10-Q for the most recent financial performance data, as this 8-K contains none.